D. Ponraju

Bio: D. Ponraju is an academic researcher from Indira Gandhi Centre for Atomic Research. The author has contributed to research in topics: Aqueous solution & Core catcher. The author has an hindex of 11, co-authored 37 publications receiving 585 citations. Previous affiliations of D. Ponraju include Indian Department of Atomic Energy & Bhabha Atomic Research Centre.

Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications.

Abstract: The focus on nanotechnology in cancer treatment and diagnosis has intensified due to the serious side effects caused by anticancer agents as a result of their cytotoxic actions on normal cells. This nonspecific action of chemotherapy has awakened a need for formulations capable of definitive targeting with enhanced tumor-killing. Nanooncology, the application of nanobiotechnology to the management of cancer, is currently the most important area of nanomedicine. Currently several nanomaterial-based drug-delivery systems are in vogue and several others are in various stages of development. Tumor-targeted drug-delivery systems are envisioned as magic bullets for cancer therapy and several groups are working globally for development of robust systems.

Diglycolamide functionalized multi-walled carbon nanotubes for removal of uranium from aqueous solution by adsorption

Abstract: Diglycolamide functionalized multi-walled carbon nanotubes (DGA-MWCNTs) were synthesized by sequential chemical reactions for removal of uranium from aqueous solution. Characterization studies were carried out using FT-IR spectroscopy, XRD and SEM analysis. Adsorption of uranium from aqueous solution on this material was studied as a function of nitric acid concen- tration, adsorbent dose and initial uranium concentration. The uranium adsorption data on DGA-MWCNTs followed the Langmuir and Freundlich adsorption isotherms. The adsorption capacity of DGA-MWCNTs as well as adsorp- tion isotherms and the effect of temperature on uranium ion adsorption were investigated. The standard enthalpy, entropy, and free energy of adsorption of the uranium with DGA-MWCNTs were calculated to be 6.09 kJ mole -1 , 0.106 kJ mole -1 K -1 and -25.51 kJ mole -1 respectively at 298K. The results suggest that DGA-MWCNTs can be used as efficient adsorbent for uranium ion removal.

Sustainable technologies for water purification from heavy metals: review and analysis

Abstract: Water pollution is a global problem threatening the entire biosphere and affecting the life of many millions of people around the world. Not only is water pollution one of the foremost global risk factors for illness, diseases and death, but it also contributes to the continuous reduction of the available drinkable water worldwide. Delivering valuable solutions, which are easy to implement and affordable, often remains a challenge. Here we review the current state-of-the-art of available technologies for water purification and discuss their field of application for heavy metal ion removal, as heavy metal ions are the most harmful and widespread contaminants. We consider each technology in the context of sustainability, a largely neglected key factor, which may actually play a pivotal role in the implementation of each technology in real applications, and we introduce a compact index, the Ranking Efficiency Product (REP), to evaluate the efficiency and ease of implementation of the various technologies in this broader perspective. Emerging technologies, for which a detailed quantitative analysis and assessment is not yet possible according to this methodology, either due to scarcity or inhomogeneity of data, are discussed in the final part of the manuscript.

In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles

Abstract: Iron oxide nanoparticles (IONPs) have been extensively used during the last two decades, either as effective bio-imaging contrast agents or as carriers of biomolecules such as drugs, nucleic acids and peptides for controlled delivery to specific organs and tissues. Most of these novel applications require elaborate tuning of the physiochemical and surface properties of the IONPs. As new IONPs designs are envisioned, synergistic consideration of the body's innate biological barriers against the administered nanoparticles and the short and long-term side effects of the IONPs become even more essential. There are several important criteria (e.g. size and size-distribution, charge, coating molecules, and plasma protein adsorption) that can be effectively tuned to control the in vivo pharmacokinetics and biodistribution of the IONPs. This paper reviews these crucial parameters, in light of biological barriers in the body, and the latest IONPs design strategies used to overcome them. A careful review of the long-term biodistribution and side effects of the IONPs in relation to nanoparticle design is also given. While the discussions presented in this review are specific to IONPs, some of the information can be readily applied to other nanoparticle systems, such as gold, silver, silica, calcium phosphates and various polymers.

Magnetic Nanoparticles in Cancer Theranostics.

Abstract: In a report from 2008, The International Agency for Research on Cancer predicted a tripled cancer incidence from 1975, projecting a possible 13-17 million cancer deaths worldwide by 2030. While new treatments are evolving and reaching approval for different cancer types, the main prevention of cancer mortality is through early diagnosis, detection and treatment of malignant cell growth. The last decades have seen a development of new imaging techniques now in widespread clinical use. The development of nano-imaging through fluorescent imaging and magnetic resonance imaging (MRI) has the potential to detect and diagnose cancer at an earlier stage than with current imaging methods. The characteristic properties of nanoparticles result in their theranostic potential allowing for simultaneous detection of and treatment of the disease. This review provides state of the art of the nanotechnological applications for cancer therapy. Furthermore, it advances a novel concept of personalized nanomedical theranostic therapy using iron oxide magnetic nanoparticles in conjunction with MRI imaging. Regulatory and industrial perspectives are also included to outline future perspectives in nanotechnological cancer research.

Gold nanoparticles for cancer radiotherapy: a review

Abstract: Radiotherapy is currently used in around 50% of cancer treatments and relies on the deposition of energy directly into tumour tissue. Although it is generally effective, some of the deposited energy can adversely affect healthy tissue outside the tumour volume, especially in the case of photon radiation (gamma and X-rays). Improved radiotherapy outcomes can be achieved by employing ion beams due to the characteristic energy deposition curve which culminates in a localised, high radiation dose (in form of a Bragg peak). In addition to ion radiotherapy, novel sensitisers, such as nanoparticles, have shown to locally increase the damaging effect of both photon and ion radiation, when both are applied to the tumour area. Amongst the available nanoparticle systems, gold nanoparticles have become particularly popular due to several advantages: biocompatibility, well-established methods for synthesis in a wide range of sizes, and the possibility of coating of their surface with a large number of different molecules to provide partial control of, for example, surface charge or interaction with serum proteins. This gives a full range of options for design parameter combinations, in which the optimal choice is not always clear, partially due to a lack of understanding of many processes that take place upon irradiation of such complicated systems. In this review, we summarise the mechanisms of action of radiation therapy with photons and ions in the presence and absence of nanoparticles, as well as the influence of some of the core and coating design parameters of nanoparticles on their radiosensitisation capabilities.